Viewing Study NCT06609304


Ignite Creation Date: 2025-12-24 @ 9:20 PM
Ignite Modification Date: 2026-04-04 @ 6:18 AM
Study NCT ID: NCT06609304
Status: RECRUITING
Last Update Posted: 2024-10-15
First Post: 2024-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
Sponsor:
Organization: